Serotonergic neurotransmission mediated cognitive dysfunction in two mouse models of sepsis‐associated encephalopathy
Authors:
Open Access
- 3 March 2024
- journal article
- research article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 30 (3) , e14655
Abstract
Background: Patients with sepsis‐associated encephalopathy (SAE) often exhibit cognitive impairments. Despite this, the underlying mechanisms of SAE remain largely unexplored. Here, we explored the role of serotonergic neurotransmission in cognitive dysfunction of two mouse models of SAE.Methods: The mouse models of SAE were established by injection of lipopolysaccharide (LPS, 10 mg/kg, intraperitoneal) and cecal ligation puncture (CLP) respectively. Barnes maze, new object recognition test and open field test were used to evaluate the effects of fluoxetine (selective serotonin reuptake inhibitor) and cyproheptadine (nonselective 5‐HT2 receptor antagonist) on cognition and motor activity of mice. Additionally, WAY100635 (5‐HT1A receptor antagonist) was co‐administered with fluoxetine to explore the mechanism underlying effect of fluoxetine on cognitive impairments of SAE. Enzyme‐linked immunosorbent assay (ELISA) was performed to determine 5‐HT levels in hippocampus, brainstem and frontal lobe of experimental groups.Results: Both LPS‐induced sepsis and CLP induced sepsis resulted in a notable learning deficit. Fluoxetine ameliorated, while cyproheptadine aggravated, cognitive impairment in two classic mouse models of SAE. The cognition‐enhancing effect of fluoxetine is reversed by WAY100635. Decreased 5‐HT levels in hippocampus, brainstem and frontal lobe were observed in LPS septic model and CLP septic model. Notably, both fluoxetine and cyproheptadine significantly increased 5‐HT levels in those brain regions in LPS septic model. Additionally, fluoxetine significantly increased 5‐HT levels in frontal lobe of CLP septic model.Conclusions: Our study demonstrated that serotonergic neurotransmission plays a significant role in mechanisms underlying cognitive impairment in SAE. These findings contribute to identification of novel targets to prevent and arrest cognitive impairment in SAE.Keywords
Funding Information
- Xiangya Hospital, Central South University
This publication has 35 references indexed in Scilit:
- Dissociable Effects of Selective 5-HT2A and 5-HT2C Receptor Antagonists on Serial Spatial Reversal Learning in RatsNeuropsychopharmacology, 2007
- Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesiaBrain Research, 2006
- Long-term outcome and quality of life of patients treated in surgical intensive care: a comparison between sepsis and traumaCritical Care, 2006
- The effect of intrahippocampal injections of ritanserin (5HT antagonist) and granisetron (5HT antagonist) on learning as assessed in the spatial version of the water mazeBehavioural Brain Research, 2005
- Serotonin receptors : their key role in drugs to treat schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003
- Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled studyEuropean Neuropsychopharmacology, 2003
- Postmortem serotoninergic correlates of cognitive decline in Alzheimer??s diseaseNeuroReport, 2002
- 5-HT system and cognitionNeuroscience & Biobehavioral Reviews, 1999
- Sepsis facilitates brain serotonin activity and impairs learning ability in ratsBrain Research, 1999
- 5-HT2 receptor antagonists and migraine therapyJournal of Neurology, 1991